IFI-M · PB Tissue-Specific Series

Specimen SS-F-M2-03490 // MULTI-AXIS · IFI-M

PB Tissue-Specific Series I-IV-A

Brassica nigra

Black Mustard

Tier IPB Tissue-Specific Series

Target Trait

1.1×

fold-change

Sharp+Bitter-Attenuation tissue-specific dual expression

Technical Specifications

SKU

SS-F-M2-03490

Genomic Edits

4

GC Content

43.5%

Construct Length

2,881 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1 + TAS2R38 (suppression)

IFI Score

110

Pathway Edits

  • TRPA1 pathway primary gene cluster overexpression for sharp axis activation
  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • Bidirectional promoter system for synchronized P+B dual-axis co-expression
  • Metabolic flux partitioning between IFI-P and IFI-B pathway branches via carbon flow optimization

Key Interventions

Dual-receptor co-activation via synchronized TRPA1 and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous sharp and bitter-attenuation accumulation without competing pathway suppressionTissue-specific dual expression for PB multi-axis integrationCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I PB dual-axis tissue-specific platform for food ingredient applications requiring verified combined sharp+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?